Gary A Lyons

Director, Travere Therapeutics, Inc.; Director, Neurocrine Biosciences

Bought, 12 months

$0.0M

Sold, 12 months

$3.3M

Companies

Latest trade

Aug 18, 2026

Companies

Travere Therapeutics, Inc.Director −$1.0M Neurocrine BiosciencesDirector −$2.3M

Trades

TVTX Sold 5,000 shares at $63.38 · planned $0.3M Aug 18

TVTX Sold 5,000 shares at $63.20 · planned $0.3M Aug 17

TVTX Sold 8,000 shares at $41.07 · planned $0.3M Apr 14

NBIX Sold 15,000 shares at $152.61 · planned $2.3M Dec 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.